ConductScience.org, home

Paper3260237

Leu-M1 immunoreactivity and prognosis in medullary carcinomas of the thyroid gland.

Schröder S and 5 others. J Cancer Res Clin Oncol, 1988. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Leu-M1 immunoreactivity and prognosis in medullary carcinomas of the thyroid gland. Papers, record 3260237. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3260237

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Leu-M1 immunoreactivity and prognosis in medullary carcinomas of the thyroid gland.
PubMed
Journal
J Cancer Res Clin Oncol
PubMed
Year
1988
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
0.65
iCite
Revised in PubMed
2025-07-19
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schröder SS
2Schwarz WW
3Rehpenning WW
4Dralle HH
5Bay VV
6Böcker WW

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, Differentiation, T-LymphocyteMajor topic
CarcinomaMajor topic
Thyroid NeoplasmsMajor topic
Humans
Immunohistochemistry
Prognosis

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13600813Leu-M1 immunoreactivity in the human brain. Discrimination between different tumors and between neoplastic and brain tissue.Naturwissenschaften1987https://conductscience.org/library/papers/3600813PubMed
26741873Leu M1 and peanut agglutinin stain the neoplastic cells of Hodgkin's disease.Am J Clin Pathol1984https://conductscience.org/library/papers/6741873PubMed
33348166Dendritic/Langerhans cells and prognosis in patients with papillary thyroid carcinomas. Immunocytochemical study of 106 thyroid neoplasms correlated to follow-up data.Am J Clin Pathol1988https://conductscience.org/library/papers/3348166PubMed
46179666A monoclonal antibody (MMA) that identifies a differentiation antigen on human myelomonocytic cells.Clin Immunol Immunopathol1982https://conductscience.org/library/papers/6179666PubMed
52859923Medullary carcinoma of thyroid. Biologic behavior of the sporadic and familial neoplasm.Cancer1985https://conductscience.org/library/papers/2859923PubMed
66891931Membrane-associated, fucose-containing glycoproteins and glycolipids of cultured epithelial cells from human colonic adenocarcinoma and fetal intestine.Eur J Cancer Clin Oncol1982https://conductscience.org/library/papers/6891931PubMed
73511719L&H variants of Reed-Sternberg cells express sialylated Leu M1 antigen.Am J Pathol1986https://conductscience.org/library/papers/3511719PubMed
82984898Prognostic factors of papillary, follicular and medullary carcinomas of the thyroid gland. Retrospective multivariate analysis of 216 patients with a median follow-up of 11 years.Acta Radiol Oncol1985https://conductscience.org/library/papers/2984898PubMed
93092632Leu-M1 immunoreactivity in nonhematopoietic neoplasms and myeloproliferative disorders. An immunoperoxidase study of paraffin sections.Am J Clin Pathol1986https://conductscience.org/library/papers/3092632PubMed
103309230Helix pomatia and Ulex europeus lectin binding in human breast carcinoma.J Pathol1987https://conductscience.org/library/papers/3309230PubMed
117125073Management of medullary carcinoma of the thyroid.Am J Surg1982https://conductscience.org/library/papers/7125073PubMed
122422942Antigenic phenotype of malignant mesotheliomas and pulmonary adenocarcinomas. An immunohistologic analysis demonstrating the value of Leu M1 antigen.Am J Pathol1986https://conductscience.org/library/papers/2422942PubMed
132859145Medullary thyroid carcinoma and calcitonin.Dan Med Bull1985https://conductscience.org/library/papers/2859145PubMed
146503683Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients.Medicine (Baltimore)1984https://conductscience.org/library/papers/6503683PubMed
156723379Clinical traits in medullary carcinoma of the thyroid.Dan Med Bull1984https://conductscience.org/library/papers/6723379PubMed
162418697Medullary carcinoma of the thyroid gland. Clinical, pathological, and immunohistochemical features with review of the literature.Am J Surg Pathol1985https://conductscience.org/library/papers/2418697PubMed
176166661Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.J Histochem Cytochem1981https://conductscience.org/library/papers/6166661PubMed
184645861On medullary carcinoma of the thyroid.Acta Pathol Microbiol Scand Suppl1972https://conductscience.org/library/papers/4645861PubMed
193887932Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues.Am J Pathol1985https://conductscience.org/library/papers/3887932PubMed
203085523Leu-M1 antigen in human neoplasms. An immunohistologic study of 400 cases.Am J Surg Pathol1986https://conductscience.org/library/papers/3085523PubMed

See all 27 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
9327746Classical Hodgkin's disease. Clinical impact of the immunophenotype.Am J Pathol1997https://conductscience.org/library/papers/9327746PubMed
8972756Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumours. Preferential reactivity with malignant tumours.Virchows Arch1996https://conductscience.org/library/papers/8972756PubMed
7725748CD15 (LeuM1) immunoreactivity: prognostic factor for sporadic and hereditary medullary thyroid cancer? Study Group on Multiple Endocrine Neoplasia of Austria.World J Surg1994https://conductscience.org/library/papers/7725748PubMed
7500798Blood group antigen expression in malignant tumors of the thyroid: a parallel between medullary and nonmedullary carcinomas.Langenbecks Arch Chir1995https://conductscience.org/library/papers/7500798PubMed
2499097Multiple expression of tissue markers in mucoepidermoid carcinomas and acinic cell carcinomas of the salivary glands.Virchows Arch A Pathol Anat Histopathol1989https://conductscience.org/library/papers/2499097PubMed
2280648[Progress in the diagnosis and therapy of C cell carcinoma of the thyroid gland].Langenbecks Arch Chir1990https://conductscience.org/library/papers/2280648PubMed
1355485Relationship of CD15 immunoreactivity and prognosis in sporadic medullary thyroid carcinoma.J Cancer Res Clin Oncol1992https://conductscience.org/library/papers/1355485PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3260237

GET https://conductscience.org/api/papers/v1/3260237/references?page=2